Viatris Inc. ( VTRS) - Stock Earnings
VTRS Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -340.1 million USD | 3.7 billion USD |
| 2026Q1 | 176.4 million USD | 3.5 billion USD |
| 2026Q2 | -118.8 million USD | 3.8 billion USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
VTRS Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 54.7 million USD | 15.4 billion USD |
| 2024 | -634.2 million USD | 14.7 billion USD |
| 2025 | -3.5 billion USD | 14.3 billion USD |
| 2026 Est. | — | — |
VTRS
Price: $17.60
Dividend Yield: 2.84%
Forward Dividend Yield: 2.73%
Payout Ratio: -88.89%
Dividend Per Share: 0.48 USD
Earnings Per Share: -0.37 USD
Exchange: NMS
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: United States
Volume: 6.2 million
Market Capitalization: 19.7 billion
Average Dividend Frequency: 4
Years Paying Dividends: 6
DGR3: 0.71%